Current evaluation of the millennium phytomedicine- Ginseng (I): Etymology, pharmacognosy, phytochemistry, market and regulations

Current Medicinal Chemistry

Volumn 16, Issue 19, 2009, Pages 2475-2484

  Jia, Lee ^a   Zhao, Yuqing ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Ginseng; Ginseng market; Ginsenosides; Pharmacognosy; Phytomedicine; Traditional chinese medicine

Indexed keywords

GINSENG EXTRACT; GINSENOSIDE;

CHINESE MEDICINE; DRUG ISOLATION; DRUG MARKETING; GINSENG; GOVERNMENT REGULATION; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PHARMACOGNOSY; PHYTOCHEMISTRY; QUALITY CONTROL; REVIEW;

GINSENOSIDES; GOVERNMENT REGULATION; MEDICINE, CHINESE TRADITIONAL; PANAX; PHYTOTHERAPY;

EID: 70349397280     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709788682146     Document Type: Review

References (49)

1. Jia, L. Global governmental investment in nanotechnologies. Curr. NanoSci., 2005, 1, 263-266.
2. Liu, X.D.; Jia, L. The conduct of drug metabolism studies considered good practice (I): Analytical systems and in vivo studies. Curr. Drug Metab., 2007, 8, 815-821.
3. Court, W.E. Ginseng: The Genus Panax. Harwood Academic Publishers, Newark, New Jersey. 2000.
4. Yun, T.K. Brief introduction of Panax ginseng C.A. Meyer. J. Korean Med. Sci., 2001, 16, 53-55.
5. Coates, P.; Blackman, M.; Crag, G. Ginseng, Asian (Panax ginseng). Encyclopedia of Dietary Supplements. 2005, pp. 265-277. Marcel Dekker, New York, NY.
6. Blumenthal, M.; Goldberg, A.; Brinckman, J. Ginseng root. In: Herbal medicine: Expanded commission monographs. Lippincott Williams & Wilkins, Newton, MA, 2000, pp. 170-177.
7. WHO. "Radix Ginseng", In, WHO Monographs on Selected Medicinal Plants, Geneva: World Health Organization, 1999, pp. 168-182.
8. Fleming, T. Physicians' desk references for herbal medicine. 2nd ed. Medical Economics Co., Montvale, NJ. 2000, pp. 346-351.
9. Blumenthal, M. Asian ginseng: Potential therapeutic uses. Adv. Nurse Practice, 2001, 9, 26-28.
10. Tyler, V.E. The honest herbal-A sensible guide to the use of herbs and related remedies. 3rd ed. New York: Haworth Press, 1993.
11. Liberti, L.E.; Der Mardersian, D.A. Evaluation of commercial ginseng products. J. Pharm. Sci., 1978, 10, 1487-1489.
12. Philipson, J.D.; Anderson, L.A. Ginseng quality safety and efficacy. Pharm. J., 1984, 232, 161-165.
13. Liu, C.X.; Xiao, P.G. Recent advances on ginseng research in China. J. Ethnopharmacol., 1992, 36, 27-38.
14. Jang, D.J.; Lee, M.S.; Shin, B.C.; Lee, Y.C.; Ernst, E. Red ginseng for treating erectile dysfunction: A systematic review. Br. J. Clin. Pharmacol., 2008, 66, 444-450.
15. Persons, S. American ginseng: Green gold. Bright Mountain Books Inc. Asheville, NC., USA, 1994.
16. Bozak, G.; Bailey, W. G. Ginseng production in north America. International Conference of Ginseng and Allied Plants, Harbin, China. 1995.
17. Zhao, Y.; Wang, W.; Han, L.; Rayburn, E.R.; Hill, D.L.; Wang, H.; Zhang, R. Isolation, structural determination, and evaluation of the biological activity of 20(S)-25-methoxyl-dammarane-3beta,12beta, 20-triol [20(S)-25-OCH3-PPD], a novel natural product from Panax notoginseng. Med. Chem., 2007, 3, 51-60.
18. Jiang, B.; Wang, C.; Han, Y.; Hu, X.; Zheng, L.; Zhao, Y. Isolation and identification of minor bioactive saponins from the leaves of Panax notoginseng. Zhong Yao Cai., 2004, 27, 489-91.
19. Davydov, M.; Krikorian, A.D. Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (Araliaceae) as an adaptogen: A closer look. J. Ethnopharmacol. 2000, 72, 345-393.
20. Hankins, A. The Chinese Ginseng Industry. The Business of Herbs. Jemez Springs, New Mexico, 1997, Vol. 25.
21. Hankins, A. Producing and marketing wild simulated ginseng in forest and agroforestry systems. 2000. http://www.ext.vt.edu/pubs/ forestry/354-312/354-312.pdf
22. Blumenthal, M. Herb sales down 15% in mainstream market. Herbalgram, 2001, 51, 69.
23. Attele, A.S.; Wu, J.A.; Yuan, C.S. Ginseng pharmacology: Multiple constituents and multiple actions. Biochem. Pharmacol., 1999, 58, 1685-1693.
24. Hall, T.; Lu, Z.Z.; Yat, P.N.; Fitzloff, J.F.; Arnason, J.T.; Awang, D.V.C.; Fong, H.H.S.; Blumenthal, M. Evaluation of consistency of standardized Asian ginseng products in the ginseng evaluation program. HerbalGram, 2001, 52, 31-45.
25. Pan European Federation of TCM Societies. The development of Chinese Pharmacopoeia. 2007, http://www.pefots.com.
26. Kim, K.H.; Lee, Y.S.; Jung, I.S.; Park, S.Y.; Chung, H.Y.; Lee, I.R.; Yun, Y.S. Acidic polysaccharide from Panax ginseng, ginsan, induces Th1 cell and macrophage cytokines and generates LAK cells in synergy with rIL-2. Planta Medica., 1998, 64, 110-5.
27. Shim, J.Y.; Han, Y.; Ahn, J.Y.; Yun, Y.S.; Song, J.Y. Chemoprotective and adjuvant effects of immunomodulator ginsan in cyclophosphamide- treated normal and tumor bearing mice. International Journal of Immunopathology. Pharmacology, 2007, 20, 487-497.
28. Qiu, Y.; Lu, X.; Pang, T.; Ma, C.F.; Li, X.; Xu, G.W. Determination of radix ginseng volatile oils at different ages by comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry. J. Sep. Sci., 2008, 31, 3451-3457.
29. Fuzzati, N. Analysis methods of ginsenosides. J. Chromatogr. B 2004, 812, 119-133.
30. Kitts, D.D.; Hu, C. Efficacy and safety of ginseng. Pub. Health Nutr., 2000, 3(4A), 473-485.
31. Hall, T.; Lu, Z.Z.; Yat, P.N.; Fitzloff, J.F.; Arnason, J.T.; Awang, D.V.C.; Fong, H.H.S.; Blumenthal, M. An introduction to the ginseng evaluation program. HerbalGram, 2001, 52, 27-30.
32. Ma, Y.C.; Zhu, J.; Luo, L. A comparative evaluation of ginsenosides in commercial ginseng products and tissue culture samples using HPLC. J. Herb Spices Med. Plants, 1995, 3, 41-50.
33. USP 27 NF 22, United States Pharmacopeial Convention Inc., Rockville, MD, 2004, p. 2005.
34. European Pharmacopoeia, 4th ed., Council of Europe, Strasbourg, 2002, p. 1244.
35. Li, W.; Fitzloff, J.F. HPLC determination of ginsenosides content in ginseng dietary supplements using ultraviolet detection. J. Liq. Chromatogr. Related Tech., 2002, 25, 2485-2495.
36. Court, W.A.; Hendel, J.G.; Elmi, J. Reversed-phase high-performance liquid chromatography determination of ginsenosides of Panax quinquefolium. J. Chromatogr. A, 1996, 755, 11-17
37. Zhou, W.; Li, J.; Li, X.; Yan, Q.; Zhou, P. Development and validation of a reversed-phase HPLC method for quantitative determination of ginsenosides Rb1, Rd, F2, and compound K during the process of biotransformation of ginsenoside Rb1. J. Sep. Sci., 2008, 31, 921-925.
38. Kwon, S.W.; Han, S.B.; Park, H.; Kim, J.M.; Park, M.K.; Park, J.H. Liquid chromatographic determination of less polar ginsenosides in processed ginseng. J. Chromatogr. A, 2001, 921, 335-339.
39. Xie, G.; Plumb, R.; Su, M.; Xu, Z.; Zhao, A.H.; Qiu, M.F.; Long, X.; Liu, Z.; Jia. W. Ultra-performance LC/TOF MS analysis of medicinal Panax herbs for metabolomic research. J. Sep. Sci., 2008, 31, 1015-1026.
40. Akao,T.; Kanaoka, M.; Kobashi, K. Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration: Measurement of compound K by enzyme immunoassay. Biol. Pharm. Bull., 1998, 21, 245-249.
41. Lee, B.H.; Lee, S. J.; Hui, J. H. In vitro antigenotoxic activity of novel ginseng saponin metabolites formed by intestinal bacteria. Planta Medica, 1998, 64, 500-503.
42. Shin, J.E.; Park, E. K. Cytotoxicity of compound K (IH-901) and ginsenoside Rh2, main biotransformants of ginseng saponins by bifidobacteria, against some tumor cells. J. Ginseng Res., 2003, 27, 129-134.
43. Chen, G.T.; Yang, M.; Song, Y.; Lu, Z.Q.; Zhang, J.Q.; Huang, H.L.; Wu, L.J.; Guo, D.A. Microbial transformation of ginsenoside Rb1 by Acremonium strictum. Appl. Microbiol. Biotech., 2008, 77, 1345-1350.
44. Lee, J.Y.; Shin, J. W.; Chun, K. S. Antitumor promotional effects of a novel intestinal bacterial metabolite (IH-901) derived from the protopanaxadiol type ginsenosides in mouse skin. Carcinogenesis, 2005, 26, 359-367.
45. Bea, E.A.; Park, S.Y.; Kim, D.H. Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol. Pharm. Bull., 2000, 23, 1481-1485.
46. Han, Y.; Sun, B.; Hu, X.; Zhang, H.; Jiang, B.; Spranger, M.I.; Zhao, Y. Transformation of bioactive compounds by Fusarium sacchari fungus isolated from the soil-cultivated ginseng. J. Agri. Food Chem., 2007, 55, 9373-9.
47. He, K.; Liu, Y.; Yang, Y.; Li, P.; Yang, L. A dammarane glycoside derived from ginsenoside Rb3. Chem. Pharm. Bull., 2005, 53, 177-9.
48. Zhang, X.R.; Zhang, D.; Xu, J.H.; Gu, J.K.; Zhao, Y.Q. Determination of 25-OH-PPD in rat plasma by high-performance liquid chromatography-mass spectrometry and its application in rat pharmacokinetic studies. J. Chromatogr. B, 2007, 858, 65-70.
49. Popovich, D.G.; Kitts, D.D. Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line. Arch. Biochem. Biophys., 2000, 406, 1-8.